Ichiza "Glidiab MV": imiyalelo, real

Kuba therapy nokugcinwa kuhlobo lwesibini seswekile, apho insulin ukhuthaza ekuvelisweni kweemolekyuli ezisekelwe indlela esetyenziswayo gliclazide. Le nto yemvelaphi sulfonylurea yelo isizukulwana yesibini.

iimpawu ngokubanzi

Medicine "Glidiab MB 30" uthathwa ukuba ezilingana Russian of "Diabeton MV" iziyobisi French. Efumanekayo Chemical-Pharmaceutical Plant "Akrikhin" kummandla eMoscow.

Le medicament inxulumene arhente ngomlomo hypoglycemic azipilisi ukuba ukukhululwa iguqulwe kancinane. Umbala ahlelwe omhlophe okanye cream inokuba amabala ibhastile. Iipilisi zifana iisilinda caba ukuba chamfer.

iphakheji UMboleki-pack. Isenokuba iipilisi 30 okanye 60 apakishwe kwi kwiipleyiti blister.

isakhiwo

Ngokungafaniyo iziyobisi "Diabeton CF" kunye ne nedosi ye-0,060 g gliclazide, y medicament "Glidiab CF" imali efanayo isithako esebenzayo ezisezantsi kabini, nto leyo 0,030 g

Xa izithako tableting engasebenziyo ziquka hydroxypropylmethylcellulose, aerosilovye molekyuli, nemagnesium stearate, microcrystalline kwincindi.

Kukho kwakhona ichiza "Glidiab" kunye ukukhululwa aqhelekileyo ukwimo esebenzayo. Izikali ipilisi nganye 0.08 g gliclazide.

njani

Okuqhotyoshelwe kule medicament "Glidiab MV" yemiyalezo ichaza inyathelo gliclazide ukuba usebenzisa ukukhuthazwa insulin secretion kwi β-iiseli, ise-pancreas.

Phantsi yempembelelo amacwecwe insulinosekretornaya msebenzi le molekyuli glucose nezihlunu neuropathy babe novakalelo ngakumbi insulin hormone.

Muscle glycogen, ukuba enzayimi intracellular ebonisa ukusebenza enkulu. Kukho kunciphiso lokuphumla ukususela ekuqaleni ukusetyenziswa ukutya ukumkhulula hormone. Benzisa insulin secretion ngelo kwincopho ekuqaleni eyahlukileyo kwezinye uhlobo gliclazide sulfonylurea, nto leyo ethatha indawo yesibini kwisigaba. Kuyancipha postprandial glucose.

Ukuphucula microcirculation kwenzeka ngokuhlanganisa adhesion zegazi kunye iseli normalizing permeability semithambo, nokunciphisa uphuhliso lweenkqubo mikrotromboznyh atherosclerotic, abasabela ukuncitshiswa wokupheliswa zendalo egazi. Ukwehla ukukwazi ukuphendula izakhiwo receptor kwi imithambo yegazi kwemolekyuli adrenaline.

Ichiza ezinokucothisa phantsi umlinganiswa isigaba retinopathy seswekile, kwi nonproliferative. arhente unyango elide ngokungqinelana nemiqathango iindawo ekulelona nomonakalo wezintso seswekile onoxanduva ukuhluza, oko kwenza kube lula ukuba ziyakwehlisa ngokubonakalayo kukhuthaza iiprothini nomchamo.

Ichiza ayinyuki ubunzima umzimba, kodwa kunoko, kunciphisa ngenxa umphumo kumabakala okuqala ukukhululwa insulin. Akatsho ukuba bandiqumbise insulinemia kwalo.

Kungani isicelo

Oogqirha bacebisa ukusetyenziswa kweziyobisi sugar ophezulu egazini isidanga sesibini. Unyango lwenziwa ukususela kancinane ukutya kunye nomsebenzi ngokulinganisela.

Ukuze medicament "Glidiab CF" Kubonakala ezinxulumene nokhuselo ngezimvo ukuphazamiseka seswekile ebonakala nephropathy, retinopathy, iposi engabalulekanga kunye stroke.

Indlela yokusebenzisa

Indlela nomthamo sikhethelwe ukuba isigulane ngamnye, banikwe ukubonakalalisa esi sifo, uyazikhomba glucose kwi ungatyanga kwaye emva kwemizuzu 120 emva kokuba kudliwe isidlo.

Kuba iziyobisi "Glidiab MV" umyalelo kwi isicelo unika idosi sokuqala yemihla ngemihla ka-0.03 g, okulingana tablet omnye. Olu xi iboniswe kwizigulane ezindala emva kweminyaka engama-65. Amayeza asetyenziswa ngomlomo Icwecwe enye ekuseni xa isidlo sakusasa.

Ukuba kuyimfuneko, idosi inyuswe qho emva kweeveki ezimbini. Inani eliphezulu elivunyelwe ngamini-nye ukuya kuthatha malunga 0,120 g, ulungelelene amacwecwe-4.

Le medicament "Glidiab CF" lalisetyenziswa endaweni enegama elifanayo ukukhululwa amayeza eqhelekileyo, usebenzisa iipilisi 1-4 ngosuku.

Its kudityaniswe iindlela hypoglycemic biguanide inyathelo, alpha-glucosidase inhibitor le iimolekyuli-insulin.

Xa izifo sezintso ukusebenza ubuthakathaka okanye ngcathu, xa izinga yokususwa creatinine kweelitha ngaphantsi kwe 0.080 sekhinzi ngomzuzu kwaye ukunciphisa nomthamo.

Xa ungakwazi ukuthatha

Tablets "Glidiab MV" yemiyalezo ucebisa ukuba usebenzise ifomu yokuqala kwezifo seswekile seswekile kwi ketones eziphezulu umchamo, paresis sengqhele kwi hyperosmolar isiqaqa seswekile kunye precoma ngenxa utyando ezinkulu niyitshise ngomlilo umenzakalo, iinkqubo zonxinzelelo xa kuyimfuneko insulin unyango.

Izimo: Ukuphazamiseka kakhulu kwesibindi okanye nokusebenza intso, kwesisu isithintelo, ukutshintsha ukufunxeka ukutya, uphuhliso imeko hypoglycemic.

Awukwazi ukusebenzisa kwizigulane nangecesina, leukopenia, ukukhulelwa, umhlaza webele-ibele ukubanyamezela ngokugqithisileyo izithako, iziyobisi.

Isilumkiso iyafuneka xa kulawulwa amayeza, yinkathalelo ebalulekileyo kunye nokukhethwa lwendlela kwizigulane abo ukuxhomekeka utywala kunye izitenxo kwi le ndlala lengqula.

Iimpawu zonyango

Xa "Glidiab MV" umyalelo kweziyobisi kwi iingongoma imfuneko ukudibanisa ube elisezantsi-osidingayo ukutya ukutya ziqulathe isiqulatho ekudleni elisezantsi. Kufuneka esweni rhoqo xi glucose kwi egazini kusasa, ngaphambi nasemva kwesidlo.

Ukuba utyando okanye decompensation imeko seswekile, mhlawumbi ukusungulwa insulin ithetha.

Kukho izilumkiso gipoglikemichekogo nkqubo lwenzeka kwi ukusetyenziswa ethyl utywala, a non-steroidal arhente anti-ezithintela ukosuleleka kunye nokungabikho ngamandla. Ukusela utywala kungabangela disulfiramopodobnyh syndrome, kunye nokuqaqamba intloko kunye nesisu, isicaphucaphu nokugabha.

Kuyimfuneko ukuba ukunyenyisa umthamo amayeza ngexesha ntshikilelo emzimbeni okanye emphefumlweni kunye yokutya ngesiquphe.
Ngakumbi lokuba indlela ngabantu abadala, izigulane ukutya engalungelelananga okanye ulihlwempu, izigulane ephelile abaphethwe ukuswela kwenkqubo adrenal-yebhinqa.

Kumanqanaba okuqala isicelo beziyobisi ekukhetheni umthamo, ukuba kukho ukuthambekela kwintlekele hypoglycemic, akukho mfuneko ukwenza iintshukumo ezidinga ukuba ukwanda ingqalelo kunye reactions lengqondo ngokukhawuleza.

ukusabela ezingalunganga

Esebenzisa "Glidiab MV" umyalelo luquka ulwazi ukuhlukunyezwa amalungu yonyango kwi ukungaphumeleli kwimo tablet, ukusetyenziswa kunye nokungondleki kakuhle. Ngokubanzi, ukuncitshiswa glucose kwi yegazi ebangela kukuvela intlungu intloko, ukudinwa, ulambile, singenamandla, ukuba buthathaka, ndlongo, yoxinaniso amahlwempu, chaza edakumbisayo nje ngephanyazo ixhala. Kwakhona kukho utshintsho Ukunakana into ebonwayo, lafa, kwebala kunye disorder convulsive, isiyezi, gipersomniyai, ukuphefumla nzulu, sinciphise izinga intliziyo.

izitho zokugaya kuvelisa ezizuzwa ngohlobo malabsorption, isicaphucaphu, urhudo, ukungabi namdla anorexic, ukuphazamiseka ezisebenza iiseli zesibindi, senyongo cholestatic, ukwandisa ukusebenza enqanda transaminase.

iinkqubo engathandekiyo kwinkqubo hematopoietic ezinxulumene ukuncipha ngehemoglobin kunye leukocyte nenombolo zegazi iiseli.

Eli chiza ingenza ziyabagulisa ngohlobo sokudlathuka kweenwele, urticaria, makulo-papular angawokubhuda.

isingeniso kakhulu

Okuqhotyoshelwe njengendlela "Glidiab MV" umyalelo kwi elumnkisa nxamnye libanda, nto leyo kubonakaliswa ukuncipha plasma glucose yoxinaniso. Ukuba imithi eyomeleleyo kwemfuneko bangenza ukuphuhlisa isiqaqa hypoglycemic.

Ukuze athintele umntu anikwe kancinane ukutya hydrocarbon wendele kakuhle, umzekelo, intwana iswekile. Xa umntu akakho zingqondweni, yena eyaziswa Kwangale-40 epesenti dextrose okanye glucose isisombululo kwaye bafake kungena esihlunwini of glucagon xa isixa-1 mg. Ukuba isigulana niphaphile, ngoko kuyanyanzeleka ukuba badle hydrocarbon wendele kakuhle ukuphepha phinda ukuhlasela hypoglycemic.

Ukudityaniswa kunye amayeza

Umsebenzi hypoglycemic le medicament "Glidiab CF 30 mg" luyaphuculwa ngokungenisa retarder ukufana angiotensin iguqulela enzyme kunye nohlobo oxidase Monoamine receptor blocker iimanyano beta adrenozavisimyh kunye H2 gistaminozavisimyh cimetidine esekelwe, kwaye flukonazolovyh amachiza mikonazolovyh nokubola, non-steroidal anti-ukudumba agents phenylbutazone, indomethacin, diclofenac.

Isiphumo sokwandisa amacwecwe exposure usebenzisa clofibrate kunye bezafibrate, iziyobisi ethionamide antitubercular ukusuka kwiqela salicylates, ngqo iikhompawundi anticoagulant lobume coumarin, steroid, cyclophosphamide, chloramphenicol, sulfonamides kunye nempembelelo elide.

Ichiza ngempumelelo lihlisa iswekile kwi plasma yegazi ngokusebenzisa blocker of zinomgutyulo tubular, ethyl utywala, acarbose, a biguanide, insulin.

Okwehlileyo tablets ukusebenza hypoglycemic kunokubangela barbiturates, amayeza ezisekelwe epinephrine, clonidine, terbutaline, ritodrine, salbutamol, nkqu phenytoin, inhibitors of గుర్తులు ibhaloni anhydrase enzyme uhlobo acetazolamide, womchamo thiazide, amadlala le nobubovu lengqula, iziyobisi Lithium aqulethe, amayeza estrogen.

ethyl molecule utywala nefuthe ukuvela inkqubo gliclazide disulfiramopodobnyh.

Amacwecwe Icandelo Active ebangela depolarization ngesiquphe kwaye ventricular izihlunu engabalulekanga mihle xa zidibene glycosides inhliziyo.

adrenoblokatornye Beta kuthetha klonidinovye, reserpine, iziyobisi guanetidinovye tifihla hypoglycemia lwezonyango.

Views ezigulane

Akuyi kuphela eqhotyoshelwe kule medicament "Glidiab MV" umyalelo manual. Ukuphonononga uthethe ngezinto izigulane bacinge malunga ukusebenza beziyobisi. Esi sixhobo inceda izigulane ezininzi ukunciphisa yoxinaniso glucose kumanqanaba eziqhelekileyo, kwaye zidityaniswe kunye yokudla lutshintsha nomfanekiso wobomi yesigulane.

Abantu bathi inkalo ezintle tablet ukusetyenziswa kwayo lula kusasa. Njengoko awukwazi ukukhumbula imfuneko unyango ngexesha lasemini.

On amayeza "Glidiab MV" ncomo ukuba weva kwaye umlinganiswa elibi enxulumene kwawo esi sixhobo. Ngokuqhelekileyo oku kwenzeka xa Umthamo ephosakeleyo xa imali encinci amayeza emiselweyo.